- IN₹502.06bn
- IN₹470.57bn
- IN₹64.31bn
Indian pharma stocks 'breathe easy' on US tariffs exemption (updated)
Indian pharma stocks defy market slump on US tariffs exemption
India's Gland Pharma gains after Vanguard funds buy stake
Indian shares may see $1.4 billion inflows as FTSE rejig comes into effect; ICICI Bank in focus
Brief: Gland Pharma Says Conclusion Of USFDA Inspection At Company’S JNPC Facility, Visakhapatnam
India's Gland Pharma falls on as French unit "continued to bleed"
India's Gland Pharma reports higher Q3 profit as expenses drop
Brief: Gland Pharma Meets Q3 Consol Net Profit View
Brief: Gland Pharma Receives Establishment Inspection Report From US FDA For Dundigal Facility
Brief: Gland Pharma Says Shyamakant Giri Will Assume Office Of CEO
Brief: Gland Pharma ANSM Inspection At Cenexi's Fontenay Manufacturing Facility
India's Gland Pharma advances on getting US FDA nod for vitamin K drug
Brief: Gland Pharma Gets US FDA Approval For Latanoprost Ophthalmic Solution, 0.005%
India's Gland Pharma soars nearly 10% after Kotak upgrade
India's Gland Pharma posts Q2 profit drop hurt by Europe business
Brief: Gland Pharma Q2 Consol Net Profit 1.64 Billion Rupees
Brief: Gland Pharma Names Shyamakant Giri As CEO
India's Gland Pharma falls after surprise Q1 profit fall
India's Gland Pharma posts surprise fall in Q1 profit on soaring employee costs